Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1/2 1

Status

Unknown 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 15Gastrointestinal 12Genitourinary 6Thoracic 4Lymphoid 4Plasma cell 3Other hematologic neoplasm 3Head & Neck 2Sarcoma 1Other neoplasm 1Gynecologic 1Endocrine 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Multiple Myeloma 3577Neoplasms, Plasma Cell 696Lymphoma 531Lymphoma, Non-Hodgkin 480Leukemia, Lymphocytic, Chronic, B-Cell 409Hodgkin Disease 405Recurrence 404Precursor Cell Lymphoblastic Leukemia-Lymphoma 375Leukemia 373Leukemia, Myeloid, Acute 363Myelodysplastic Syndromes 331Lymphoma, Large B-Cell, Diffuse 290Lymphoma, Mantle-Cell 288Lymphoma, Follicular 284Lymphoma, B-Cell, Marginal Zone 256Burkitt Lymphoma 249Immunoglobulin Light-chain Amyloidosis 227Myeloproliferative Disorders 226Lymphoma, Large-Cell, Immunoblastic 223Neoplasms 214Hematologic Neoplasms 200Primary Myelofibrosis 186Leukemia, Myeloid, Chronic-Phase 182Leukemia, Myeloid, Accelerated Phase 173Lymphoma, T-Cell, Cutaneous 170Waldenstrom Macroglobulinemia 164Blast Crisis 162Leukemia, Myelomonocytic, Chronic 158Mycosis Fungoides 147Sezary Syndrome 146

Interventions

liposomal doxorubicin 1TKN732 1Melphalan 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Patient Participation × Plasma cell × Clear all
NCT05673083 2025-09-04

Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma

All4Cure

Active not recruiting
200 enrolled
Plasma cell

Multiple Myeloma, Patient Participation

NCT06116734 2023-11-03

Lapelga vs Gastrofil

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 3 Unknown
74 enrolled
Classical hematologyLymphoidPlasma cell

Lymphoma, Multiple Myeloma, Patient Participation, Febrile Neutropenia

NCT00985907 2020-06-17

DMV

University of California, San Francisco

Phase 1/2 Terminated
13 enrolled 8 charts
Plasma cell

Multiple Myeloma, Patient Participation, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡